The President was slated to speak on drug prices this week in what was a highly anticipated event. Yesterday, word got out that it would be postponed to a date to be determined. The health of the HHS Secretary certainly played a factor in the delay. It forces stakeholders back to the waiting game, try as they may to get a sense of which direction the Administration may go. The speech was expected to coincide with a Request for Information of some kind that is currently pending at OMB. The “HHS Strategy to Lower Drug Prices and Reduce Out-of-Pocket Costs,” while not economically significant, will certainly make people nervous until they see direction from the Administration.